相关实验视频

Updated: Jun 12, 2025

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

针对TEAD将是无痕伤口修复的潜在策略:初步研究

Ming-Yan Yang¹, Hong-Yuan Quan², Da-Lei Li¹

¹School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, No. 32 Qingquan Road, Laishan District, Yantai, Shandong 264005, China.

Acta histochemica

|December 12, 2024

概括

研究人员探索了一种新的药物,VT107,针对TEAD预防皮肤痕. 该研究发现,VT107通过抑制纤维细胞增殖和原沉积,有效地减少痕形成,提供了一个有前途的抗痕策略.

科学领域:

再生医学是一种再生医学.
皮肤病学皮肤病学
分子生物学分子生物学

背景情况:

尽管进行了广泛的研究,目前预防皮肤痕的策略仍然有限.
抑制YAP (Yes相关蛋白) 已经显示出无痕伤口修复的潜力.
针对YAP直接提出了重大可用性挑战.

研究的目的:

评估VT107的治疗潜力,一种新的TEAD自动棕化抑制剂,用于预防痕形成.
调查抑制TEAD (转录增强因子D和肌细胞增强因子2转录因子D) 的疗效,作为针对YAP的替代方案.

主要方法:

使用皮肤伤口愈合模型来评估VT107.7的影响.
分析了痕形成的关键标志物,包括纤维细胞增殖,原变性和沉积.
量化了TGF-β1 (转化生长因子β1) 和CTGF (连接组织生长因子) 的表达水平.

主要成果:

VT107在预防痕形成方面表现出显著的积极作用.
由VT107抑制导致纤维细胞增殖减少和原脱.
VT107降低了TGF-β1和CTGF的表达,以及原沉积.

结论:

用VT107抑制TEAD自动棕化是一种可行的痕预防策略.
TEAD是开发新型抗痕疗法的一个有前途的分子标.
这些发现为伤口愈合和痕管理的再生方法提供了新的见解.

关键词:

原蛋白是一种原蛋白.皮肤上的伤口愈合.痕痕的痕痕我们的 TEAD TEAD 团队.在 YAP 信号传输中.

更多相关视频

Apparatus for Harvesting Tissue Microcolumns

Apparatus for Harvesting Tissue Microcolumns

Published on: October 25, 2018

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...